Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Geschatte realtime 18:14:15 02-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2,715 USD -0,18% Intraday-grafiek van Perspective Therapeutics, Inc. +8,13% -0,91%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-0,18%+8,13%-12,10%-24,93%-0,91%-21,92%+0,93%-55,70%-61,34% 310 mln.
+4,16%+3,04%+8,38%+33,66%+84,62%+49,37%+94,17%+9,52% - 74,41 mld.
-3,11%-3,53%-9,46%-1,19%+13,76%+21,92%+74,60%+218,02%+5.289,29% 59,26 mld.
+0,89%-0,63%-3,05%+0,18%+5,17%+4,28%+34,51%-18,05%+203,27% 47,14 mld.
-0,82%-4,15%-1,78%+25,17%+14,97%+26,83%+33,67%+8,63%+223,14% 42,91 mld.
+0,15%+1,71%-0,36%+10,17%+161,75%+356,19%+696,64%+628,95% - 44,13 mld.
-1,98%-2,50%-2,75%+18,20%+15,81%+1,93%+97,10%-0,56%+1.034,94% 40,79 mld.
-0,54%+2,93%-2,87%+4,64%+5,93%+9,50%+50,41%-10,44%+144,22% 30,77 mld.
-2,68%+5,11%+10,25%+57,66%+73,51%+33,11%+19,50%-56,88% - 29,31 mld.
-0,39%-7,49%-13,91%-2,32%-37,36%-28,66%+329,68%+311,98%+648,70% 23,71 mld.
-0,21%-1,42%-6,44%-0,43%+2,02%-7,07%-13,86%-60,98% - 24,33 mld.
-2,42%-0,88%+3,77%+20,44%+11,35%+11,46%-7,65%-17,11%+97,64% 20,81 mld.
+1,32%-1,90%+2,37%+8,88%+8,09%+13,23%+150,29%+217,02%+1.888,53% 16,69 mld.
-0,43%+0,87%-11,07%-4,98%+174,96%+131,18%+326,82%+1.692,64%+635,44% 15,17 mld.
-0,72%+0,58%-15,12%-17,34% - - - - - 14,93 mld.
-3,04%+1,33%-3,59%+8,25%+20,40%-8,13%+516,45% - - 14,84 mld.
+0,43%-3,23%+2,86%+8,27%+19,97%+19,13%+43,03%-28,54%+81,88% 14,57 mld.
-0,09%-9,39%+24,36%+27,81%+30,45%-13,74% - - - 13,8 mld.
+0,83%+0,81%+0,17%+4,98%+33,77%+41,79%+163,86%+178,66%+360,93% 14,36 mld.
+0,60%-1,26%-0,89%+25,35%+44,96%+64,90%+49,52%-27,43%+245,55% 13,69 mld.
Gemiddelde -0,42%-0,73%-1,56%+10,12%+35,96%+37,12%+147,76%+175,87%+830,17% 27,8 mld.
Gewogen gemiddelde per kap. -0,22%-0,76%-0,94%+13,95%+41,44%+48,86%+146,88%+147,37%+1.315,56%
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.